# Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

> clinical trial · VERIFIED · 2026-07-20

Status: RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Ganglioneuroblastoma, Nodular

- Company: National Cancer Institute (NCI)
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06172296

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.